|
Delayed
Australian S.E.
22:38:39 2026-10-06 EDT
|
5-day change | 1st Jan Change | ||
| 0.2900 AUD | +7.41% |
|
+11.54% | -71.57% |
| 09-16 | Epiminder Says US Clinical Study Evaluating Epilepsy Monitoring Platform Enrolls 75th Patient | MT |
| 08-25 | Epiminder Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Medical Diagnostic & Testing Equipment
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 40.02M | - | - | - | - | - |
| 250B | |||||
| 156B | |||||
| 144B | |||||
| 61.45B | |||||
| 50.28B |
- Stock Market
- Stocks
- EPI Stock
- Charts Epiminder Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
